BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THER

BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ...

Related Keywords

Kim Kelderman , David Clair , Prnewswire Bio Techne Corporation , Assay Services , Bio Techne Corporation , Techne Corporation , Advanced Cell Diagnostics , Cell Diagnostics , Professional Assay Services , Vice President ,